HLS Therapeutics (HLS.V) Q3 2024 Earnings

8AugConfirmed
Q2 2024
Q3 2024
-0.26
-0.24
-0.23
-0.21

Details

Expected EPS
-0.20912247209999998
Actual EPS
-0.24726599999999999
Surprise EPS
-0.04
Surprise Percent
+18.24%

Description

HLS Therapeutics (HLS.V) has reported earnings of -0.24726599999999999 per share for Q3 2024.

0 Comments

Share your thoughts